Treponema pallidum (TP/Syphilis)
Structure, Key Antigen Targets and Research Applications
Overview
Treponema pallidum subsp. pallidum is the causative agent of syphilis, a sexually transmitted infection that can progress through multiple clinical stages and affect multiple organ systems. This highly invasive spirochete has a distinctive cell architecture and a remarkable ability to persist in the host, making it an important model for studying bacterial immune evasion, tissue dissemination, and chronic infection.
Unlike many Gram-negative bacteria, T. pallidum has a relatively unusual and sparsely populated outer membrane. Its cell envelope contains an inner cytoplasmic membrane, a peptidoglycan layer, and an outer membrane separated by a periplasmic space. The organism also possesses complex periplasmic flagella that contribute to its characteristic helical morphology and motility.
The genome of T. pallidum is relatively small, at approximately 1.04 Mb, and encodes a limited metabolic repertoire. As a result, the bacterium depends extensively on its host for nutrients and other essential metabolites. Its limited number of conventional outer membrane proteins, combined with immune evasion mechanisms and antigenic variation, contributes to its ability to persist in the host.

The bacterium's unique outer membrane architecture and antigenic variation mechanisms make it a challenging target for vaccine development and serological diagnosis.
Treponema pallidum Structure
T. pallidum is a slender, helical spirochete with a highly specialized cell envelope. The cytoplasmic membrane is surrounded by a thin peptidoglycan layer and an outer membrane. Unlike typical Gram-negative bacteria, its outer membrane contains relatively few integral membrane proteins, while numerous lipoproteins are associated with the inner membrane or periplasm. The periplasmic flagella are located between the cytoplasmic membrane and outer membrane. Their distinctive arrangement enables the organism to move through viscous environments and contributes to its ability to disseminate through host tissues. The outer membrane contains a limited set of integral outer membrane proteins, including members of the Tpr family, BamA, LptD, and other predicted β-barrel proteins. These proteins are increasingly recognized as important determinants of nutrient acquisition, host interaction, immune recognition, and vaccine development.
Key Research Targets
Key Research Targets
| Target | Key Features | Research Applications |
|---|---|---|
| Tp15 / TP0171 | Highly immunogenic 15 kDa lipoprotein | Serology, antigen characterization, antibody research |
| Tp17 / TP0435 | Highly immunogenic lipoprotein with β-barrel structure | Serology, antigenicity, host-pathogen interaction studies |
| Tp47 / TP0574 | 47 kDa immunogenic lipoprotein with carboxypeptidase activity | Serology, antigen research, host-pathogen interaction studies |
| TprK / TP0897 | Variable Tpr protein involved in antigenic variation | Immune evasion, antigenic variation, vaccine research |
| TprC / TprD | Putative surface-exposed β-barrel proteins | Outer membrane biology, host interaction, vaccine research |
| BamA / TP0326 | Essential outer membrane protein assembly factor | Outer membrane biogenesis, pathogenesis and vaccine research |
AntibodySystem Treponema pallidum Research Products
AntibodySystem provides research reagents targeting immunogenic T. pallidum proteins for studies of antigenicity, serological responses, host-pathogen interactions, and syphilis-related research.
Recombinant Proteins
| Cat. No. | Product Name |
|---|---|
| YXX23901 | Recombinant Treponema pallidum FlaB3 Protein, N-His-SUMO |
| YXX06301 | Recombinant Treponema pallidum/TP TPF1/Antigen 4D Protein, C-His |
| YXX06701 | Recombinant Treponema pallidum/TP TPF17/TP17 Protein, N-GST |
| YXX06801 | Recombinant Treponema pallidum/TP TpAg (TPP15-tmpA-TPP17-TPP47) Protein, C-His |
| YXX07001 | Recombinant Treponema pallidum/TP TPP47/TP47 Protein, C-His |
| YXX06901 | Recombinant Treponema pallidum/TP tmpA Protein, C-His |
| YXX07002 | Recombinant Treponema pallidum TPP47/TP47 (G239V) Protein, C-His |
| YXX06802 | Recombinant Treponema pallidum TPP15/TP15 Protein, C-His |
Antibodies
| Cat. No. | Product Name |
|---|---|
| PXX06802 | Anti-Treponema pallidum TpAg (TPP15-tmpA-TPP17-TPP47) Polyclonal Antibody |
| PXX06301 | Anti-Treponema pallidum TPF1/Antigen 4D Polyclonal Antibody |
| PXX23901 | Anti-Treponema pallidum FlaB3 Polyclonal Antibody |
| PXX06901 | Anti-Treponema pallidum tmpA Polyclonal Antibody |
| PXX07001 | Anti-Treponema pallidum TPP47 Polyclonal Antibody |
| PXX06701 | Anti-Treponema pallidum TPP17 Polyclonal Antibody |
| PXX06801 | Anti-Treponema pallidum TPP15/TP15 Polyclonal Antibody |
ELISA Kits
| Cat. No. | Product Name |
|---|---|
| KXX06801 | Treponema pallidum TPP15 ELISA Kit |
| KXX06701 | Treponema pallidum TPP17 ELISA Kit |
| KXX07001 | Treponema pallidum TPP47 ELISA Kit |
AntibodySystem's Treponema pallidum research portfolio supports studies of antigenicity, serological responses, host-pathogen interactions, and syphilis-related research.
AntibodySystem — Reliable Reagents for Treponema pallidum Research
AntibodySystem offers high-quality recombinant proteins, antibodies, and ELISA kits to support Treponema pallidum antigen characterization, antibody screening, vaccine studies, immune response analysis, and diagnostic assay development.
